14-15 November 2018
|European Case Law Identifier:||ECLI:EP:BA:2006:T110405.20060621|
|Date of decision:||21 June 2006|
|Case number:||T 1104/05|
|IPC class:||A61L 29/00|
|Language of proceedings:||EN|
|Download and more information:||
|Title of application:||A method for sterilising a medical device having a hydrophilic coating|
|Applicant name:||COLOPLAST A/S|
|Opponent name:||AstraZeneca AB|
|Relevant legal provisions:||
|Keywords:||Missing statement of grounds|
Summary of Facts and Submissions
I. In its decision dated 10 June 2005 the Opposition Division decided that European patent No. 1 131 112 as amended meets the requirements of the EPC.
II. The Patent Proprietor, COLOPLAST A/S, filed a notice of appeal on 22 August 2005 against the decision of the Opposition Division and paid the appeal fee on the same day. No statement of grounds was filed within the prescribed period in accordance with Article 108 EPC.
III. By a communication dated 1 December 2005 sent by registered letter with advice of delivery, the Registry of the Board informed the Appellant that no statement of grounds had been filed and that the appeal could be expected to be rejected as inadmissible. The Appellant was invited to file observations within two months.
IV. No reply from the Appellant was received within this time-limit.
Reasons for the Decision
As no written statement setting out the grounds of appeal has been filed, the appeal has to be rejected as inadmissible (Article 108 EPC in conjunction with Rule 65(1) EPC).
For these reasons it is decided that:
The appeal is rejected as inadmissible.